Mobocertinib succinate
99%
- Product Code: 211545
CAS:
2389149-74-8
Molecular Weight: | 703.8 g./mol | Molecular Formula: | C₃₆H₄₅N₇O₈ |
---|---|---|---|
EC Number: | MDL Number: | MFCD32689632 | |
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | Room temperature |
Product Description:
Used for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring EGFR exon 20 insertion mutations, as detected by an FDA-approved test. It is indicated for patients whose disease has progressed on or after platinum-based chemotherapy. Mobocertinib succinate is an oral tyrosine kinase inhibitor designed to selectively and irreversibly target EGFR exon 20 insertion mutations, which are typically resistant to conventional EGFR inhibitors. Its application offers a targeted therapy option for a molecularly defined subset of lung cancer patients, improving progression-free survival and providing an alternative to standard chemotherapy in this population.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
1g | 10-20 days | Ft38,795.27 |
+
-
|
5g | 10-20 days | Ft139,110.22 |
+
-
|
Mobocertinib succinate
Used for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring EGFR exon 20 insertion mutations, as detected by an FDA-approved test. It is indicated for patients whose disease has progressed on or after platinum-based chemotherapy. Mobocertinib succinate is an oral tyrosine kinase inhibitor designed to selectively and irreversibly target EGFR exon 20 insertion mutations, which are typically resistant to conventional EGFR inhibitors. Its application offers a targeted therapy option for a molecularly defined subset of lung cancer patients, improving progression-free survival and providing an alternative to standard chemotherapy in this population.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :